Collections
Gallery
Gallery

Gallery View

Showing 1 - 24 of 24 Records

Title (A-Z) Title (Z-A) Date (Ascending) Date (Descending)
25 50 100
Miniature of Operation Warp Speed and the COVID-19 Vaccine
Operation Warp Speed and the COVID-19 Vaccine
Miniature of Novartis' Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries' Health Care Systems
Novartis' Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries' Health Care Systems
Miniature of Takeda Pharmaceutical Company (B), the Millennium Acquisition
Takeda Pharmaceutical Company (B), the Millennium Acquisition
Miniature of Takeda Pharmaceutical Company, Becoming a Global Company (A)
Takeda Pharmaceutical Company, Becoming a Global Company (A)
Miniature of Takeda Pharmaceutical Company (C), the Future of Takeda
Takeda Pharmaceutical Company (C), the Future of Takeda
Miniature of Wyeth Pharmaceuticals: Changing the Mindsets and Behaviors of 17,000 People... One Person at a Time
Wyeth Pharmaceuticals: Changing the Mindsets and Behaviors of 17,000 People... One Person at a Time
Miniature of Compulsory Licensing, Thailand, and Abbott Laboratories
Compulsory Licensing, Thailand, and Abbott Laboratories
Miniature of Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome
Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome
Miniature of Molecular Insight Pharmaceuticals Integrated Strategy for a Development Stage Molecular Medicine Company
Molecular Insight Pharmaceuticals Integrated Strategy for a Development Stage Molecular Medicine Company
Miniature of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Miniature of Negotiating Partnerships in the Healthcare Industry (A): The Pharmac and Respire Deal
Negotiating Partnerships in the Healthcare Industry (A): The Pharmac and Respire Deal
Miniature of Exubera and Nice
Exubera and Nice
Miniature of Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations
Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations
Miniature of Connetics and Relaxin
Connetics and Relaxin
Miniature of Abbott Laboratories and Humira: Launching a Blockbuster Drug
Abbott Laboratories and Humira: Launching a Blockbuster Drug
Miniature of Zeneca's Direct-To-Consumer Advertising of Nolvadex
Zeneca's Direct-To-Consumer Advertising of Nolvadex
Miniature of Developing and Marketing a Blockbuster Drug: Lessons from Eli Lilly's Experience with Prozac
Developing and Marketing a Blockbuster Drug: Lessons from Eli Lilly's Experience with Prozac
Miniature of Vaxgen, Inc., Fighting the Aids Epidemic
Vaxgen, Inc., Fighting the Aids Epidemic
Miniature of Abbott Laboratories and Humira: Launching a Blockbuster Drug
Abbott Laboratories and Humira: Launching a Blockbuster Drug
Miniature of Merck's Us. Managed Distribution Program for the HIV Drug Crixivan
Merck's Us. Managed Distribution Program for the HIV Drug Crixivan
Miniature of Note on AIDS and the Pharmaceutical Industry
Note on AIDS and the Pharmaceutical Industry
Miniature of GlaxoSmithKline and AIDS Drugs Policy
GlaxoSmithKline and AIDS Drugs Policy
Miniature of Anglo American (A)
Anglo American (A)
Miniature of Pharmaceutical Switching
Pharmaceutical Switching

24 pharmaceuticals 6 health care 5 pharmaceuticals industry 5 strategic planning 4 emerging markets 4 ethics and social responsibility 4 human resource management / organisational behaviour 4 production and operations management 4 public relations 3 AIDS 3 economics 3 economics, politics and business environment 3 ethics 3 government policy 3 growth strategy 3 marketing strategy 3 mergers and acquisitions (M&A) 3 politics and business environment 3 strategy and general management 2 business processes 2 corporate strategy 2 entrepreneurship 2 global business 2 innovation 2 market positioning 2 marketing planning 2 medical devices 2 negotiations 2 non-market 2 partnerships 2 product introduction 2 product life cycle 2 product management 2 public policy 2 tradeoff analysis 1 Africa 1 COVID 1 South Africa 1 World Trade Organisation (WTO) 1 advertising campaign 1 advertising ethics 1 biotechnology 1 clinical trials 1 compulsory licensing 1 consultants 1 cost effectiveness 1 cross-country analysis 1 cultural clashes 1 decision making 1 development stage enterprises 1 diffusion 1 direct-to-consumer 1 distribution 1 distribution channels 1 distribution planning 1 drugs 1 econometrics 1 economic policy 1 empirical industrial organization 1 employee benefits 1 employee empowerment 1 fiscal policy 1 government and business 1 health 1 health care systems 1 health services 1 hierarchical bayes 1 innovator 1 intellectual property 1 international operations 1 leadership 1 legal aspects of business 1 legal issues 1 management of change 1 management of crises 1 market research 1 marketing campaigns 1 medical device 1 medical supplies 1 national security 1 new product marketing 1 non-market factors 1 nonmarket issues 1 patents 1 payer 1 philanthropy 1 plant management 1 political economics 1 pricing strategy 1 product development 1 provider 1 public-private partnerships 1 reimbursement 1 reimbursement systems 1 restructuring 1 risk management 1 social change 1 social issues 1 strategic alliances 1 strategy 1 vaccine 1 world economy